Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-11

Clinical Trial Update: Role of Axumin PET Scan in Germ Cell Tumor

View source ↗

Summary

This clinical trial evaluated the role of Axumin PET imaging in germ cell tumors, including testicular cancer. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Axumin (fluciclovine F-18)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Testis Cancer, Germ Cell Tumor | Status: COMPLETED